Internal cardioversion of atrial fibrillation: Marked reduction in defibrillation threshold with dual current pathways

Circulation

Volumn 96, Issue 8, 1997, Pages 2693-2700

  Cooper, Randolph A S ^a   Smith, William M ^b   Ideker, Raymond E ^b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b NONE

Author keywords

Atrium; Defribillation; Fibrillation

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOVERSION; CONTROLLED STUDY; DEFIBRILLATION; ELECTRODE; FEMALE; HEART ATRIUM FIBRILLATION; MALE; NONHUMAN; PAIN THRESHOLD; PRIORITY JOURNAL; SHEEP;

EID: 0030876149     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.8.2693     Document Type: Article

References (45)

1. Kannel WB, Abbott RD, Savage DD, McNamara PM. Epidemiologic features of chronic atrial fibrillation. N Engl J Med. 1982;306: 1018-1022.
2. Wolf PA, Dawber TR, Thomas E Jr, Kannel WB. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology. 1978;28:973-977.
3. Pai S, Torres V. Atrial fibrillation: new management strategies. Curr Prob Cardiol. 1993;18:233-300.
4. Cooper RAS, Alferness CA, Smith WM, Ideker RE. Internal cardioversion of atrial fibrillation in sheep. Circulation. 1993;87: 1673-1686.
5. Johnson EE, Yarger MD, Wharton JM. Monophasic and biphasic waveforms for low energy internal cardioversion of atrial fibrillation in humans. Circulation. 1993;88(suppl I):I-592. Abstract.
6. Murgatroyd FD, Johnson EE, Cooper RA, Lau C, Alt E, Kappenburger LJ, Smith JM, Camm AJ, Wharton JM. Safety of low energy transvenous atrial defibrillation: world experience. Circulation. 1994;90(suppl I):I-14. Abstract.
7. Murgatroyd FD, Slade AKB, Sopher SM, Rowland E, Ward DE, Camm AJ. Efficacy and tolerability of transvenous low energy cardioversion of paroxysmal atrial fibrillation in humans. J Am Coll Cardiol. 1995;25:1347-1353.
8. Cooper RAS, Johnson EE, Wharton JM. Internal atrial defibrillation in humans: the improved efficacy of biphasic waveforms and the importance of phase duration. Circulation. 1997;95:1487-1496.
9. Levy S, Ricard P, Lau C, Lok N, Camm AJ, Murgatroyd F, Kappenberger LJ, Jordaens LJ, Brugada P. Multicenter Low Energy Transvenous Atrial Defibrillation (XAD) Trial. Circulation. 1995;92(suppl I):I-472. Abstract.
10. Lau CP, Tse HF, Lee K, Lok MB, Ho DSW, Soffer MB, Camm AJ. Initial clinical experience of a human implantable atrial defibrillator. Pacing Clin Electrophysiol. 1996;19:625. Abstract.
11. Nathan AW, Bexton RS, Spurrell RAJ, Camm AJ. Internal transvenous low energy cardioversion for the treatment of cardiac arrhvthmias. Br Heart J. 1984;52:377-384.
12. Jung W, Tebbenjohanns J, Wopert C, Luderitz B. Safety, efficacy, and pain perception of internal atrial defibrillation in humans. Circulation. 1995:92(suppl I):I-472. Abstract.
13. Steinhaus DM, Cardinal D, Mongeon L, Mattson L, Waters M, Folev L, Corrigan S. Atrial defibrillation: are low energy shocks acceptable to patients? Pacing Clin Electrophysiol. 1996;19:625. Abstract.
14. Lok NS, Lau CP, Lai-Fun-Lee K, Tse HF, Avers G. Effect of different right atrial lead locations on the efficacy and tolerability of low energy transvenous atrial defibrillation with an implantable lead system. Pacing Clin Electrophysiol. 1996;19:633. Abstract.
15. Bardy GH, Ivey TD, Allen MD, Johnson G, Greene HL. Prospective comparison of sequential pulse and single pulse defibrillation with use of two different clinically available systems. J Am Coll Cardiol. 1989;14:165-171.
16. Yee R, Jones DL, Klein GJ, Sharma AD, Kallok MJ. Sequential pulse countershock between two transvenous catheters: feasibility, safety, and efficacy. Pacing Clin Electrophysiol. 1989;12:1869-1877.
17. Yee R, Klein GJ, Leitch JW, Jones DL, Leather RA, Kim YH. Improved defibrillation efficacy by combined biphasic and sequential shock delivery. Circulation. 1991;84(suppl II):II-649. Abstract.
18. Jones DL, Klein GJ, Guiraudon GM, Shanna AD, Kallok MJ, Bourland JD, Tacker WA Jr. Internal cardiac defibrillation in man: pronounced improvement with sequential pulse delivery to two different lead orientations. Circulation. 1986;73:484-491.
19. Jones DL, Klein GJ, Guiraudon GM, Sharma AD, Kallok MJ, Tacker WA Jr, Bourland JD. Sequential pulse defibrillation in man: comparison of thresholds in normal subjects and those with cardiac disease. Med Instrum. 1987;21:166-169.
20. Jones DL, Klein GJ, Guiraudon GM, Sharma AD. Sequential pulse defibrillation in humans: orthogonal sequential pulse defibrillation with epicardial electrodes. J Am Coll Cardiol. 1988;11:590-596.
21. Jones DL, Klein GJ, Rattes MF, Sohla A, Sharma AD. Internal cardiac defibrillation: single and sequential pulses and a variety of lead orientations. Pacing Clin Electrophysiol. 1988;11:583-591.
22. Jones DL, Klein GJ, Kallok MJ. Improved internal defibrillation with twin pulse sequential energy delivery to different lead orientations in pigs. Am J Cardiol. 1985;55:821-825.
23. Kallok MJ, Bourland JD, Tacker WA Jr, Jones DL, Klein GJ, Wessale JL. Optimization of epicardial electrode size and implant site for reduced sequential pulse defibrillation thresholds. Med Instrum. 1986;20:36-39.
24. Jones DL, Natale A, Kim YH, Klein GJ, Wood GK, Robarts JP. New waveforms and defibrillation in pigs: biphasic, sequential and biphasic-sequential. Proc Med Instrum. 1990;25:46. Abstract.
25. Guse PA, Walcott GP, Rollins DL, Smith WM, Ideker RE. Defibrillation electrode configurations developed from cardiac mapping that combine biphasic shocks with sequential timing. Am Heart J 1992;124:1491-1500.
26. Johnson EE, Alferness CA, Wolf PD, Smith WM, Ideker RE. Effect of pulse separation between two successive biphasic shocks given over different lead configurations on ventricular defibrillation efficacy. Circulation. 1992;85:2267-2274.
27. Guse PA, Rollins DR, Krassowska W, Wolf PD, Smith WM, Ideker RE. Effective defibrillation in pigs using interleaved and common phase sequential biphasic shocks. Pacing Clin Electrophysiol. 1993; 16:1719-1734.
28. Cooper RAS, Smith WM, Ideker RE. Early activation sites after unsuccessful internal atrial defibrillation shocks: the effect of electrode configuration. Pacing Clin Electrophysiol. 1996;19:706. Abstract.
29. Jung W, Pfeiffer D, Wolpert C, Pizzulli L, Fehske W, Schumacher B, Lewalter T, Omran H, Korte T, Luderitz B. Which patients do benefit from an implantable atrial defibrillator? J Am Coll Cardiol 1996;27:301. Abstract.
30. Krassowska W, Frazier DW, Pilkington TC, Ideker RE. Potential distribution in three-dimensional periodic myocardium, II: application to extracellular stimulation. IEEE Trans Biomed Eng. 1990; 37:267-284.
31. Lepeschkin E, Jones JL, Rush S, Jones RE. Local potential gradients as a unifying measure for thresholds of stimulation, standstill, tachyarrhythmia and fibrillation appearing after strong capacitor discharges. Adv Cardiol. 1978;21:268-278.
32. Frazier DW, Krassowska W, Chen P, Wolf PD, Dixon EG, Smith WM, Ideker RE. Extracellular field required for excitation in three-dimensional anisotropic canine myocardium. Circ Res. 1988;63: 147-164.
33. Chen P, Wolf PD, Claydon FJ III, Dixon EG, Vidaillet HJ Jr, Danieley ND, Pilkington TC, Ideker RE. The potential gradient field created by epicardial defibrillation electrodes in dogs. Circulation. 1986;74:626-636.
34. Witkowski FX, Penkoske PA, Plonsey R. Mechanism of cardiac defibrillation in open-chest dogs with unipolar DC-coupled simultaneous activation and shock potential recordings. Circulation. 1990;82:244-260.
35. Wharton JM, Wolf PD, Smith WM, Chen P, Frazier DW, Yabe S, Danieley N, Ideker RE. Cardiac potential and potential gradient fields generated by single, combined, and sequential shocks during ventricular defibrillation. Circulation. 1992;85:1510-1523.
36. Tang ASL, Wolf PD, Claydon FJ III, Smith WM, Pilkington TC, Ideker RE. Measurement of defibrillation shock potential distributions and activation sequences of the heart in three-dimensions. IEEE Trans Biomed Eng. 1988;76:1176-1186.
37. Lesigne C, Levy B, Saumont R, Birkui P, Bardou A, Rubin B. An energy-time analysis of ventricular fibrillation and defibrillation thresholds with internal electrodes. Med Biol Eng. 1976;14:617-622.
38. Yabe S, Smith WM, Daubert JP, Wolf PD, Rollins DL, Ideker RE. Conduction disturbances caused by high current density electric fields. Circ Res. 1990;66:1190-1203.
39. Jones JL, Lepeschkin E, Jones RE, Rush S. Response of cultured myocardial cells to countershock-type electric field stimulation. Am J Physiol. 1978;235:H214-H222.
40. Pansegrau DG, Abboud FM. Hemodynamic effects of ventricular defibrillation. J Clin Invest. 1970;49:282-297.
41. Dahl CF, Ewy GA, Warner ED, Thomas ED. Myocardial necrosis from direct current countershock: effect of paddle size and time interval between discharge. Circulation. 1974;50:956-961.
42. Ideker RE, Wolf PD, Alferness CA, Krassowska W, Smith WM. Current concepts for selecting the location, size, and shape of defibrillation electrodes. Pacing Clin Electrophysiol. 1991;14: 227-240.
43. Dixon EG, Tang ASL, Wolf PD, Meador JT, Fine MJ, Calfee RV, Ideker RE. Improved defibrillation thresholds with large contoured epicardial electrodes and biphasic waveforms. Circulation. 1987;76: 1176-1184.
44. Kavanagh KM, Tang ASL, Simpson E, Melnick SB, Smith WM, Ideker RE. Fibrillation recurrence sites following failed nonthoracotomy defibrillation. Circulation. 1990;82(suppl III):III-182. Abstract.
45. Johnson E, Smith W, Yarger M, Cooper R, Broughton A, Wharton JM. Clinical predictors of low energy defibrillation thresholds in patients undergoing internal cardioversion of atrial fibrillation. Pacing Clin Electrophysiol. 1994;17:742. Abstract.